Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Burkitt Lymphoma 24Prostatic Neoplasms 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Large B-Cell, Diffuse 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia, Biphenotypic, Acute 5Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 4Lymphoma 4Plasmablastic Lymphoma 3Lymphoma, T-Cell 3Lymphoma, Follicular 3Immunoblastic Lymphadenopathy 3Enteropathy-Associated T-Cell Lymphoma 3Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Hodgkin Disease 2Down Syndrome 2Carcinoma, Merkel Cell 2Carcinoma, Basal Cell 2Blast Crisis 2Vasculitis, Central Nervous System 1Urogenital Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Stiff-Person Syndrome 1Stage II Prostate Adenocarcinoma 1Rasmussen subacute encephalitis 1Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1Oropharyngeal Neoplasms 1

Interventions

Cyclophosphamide 8fludarabine phosphate 7tagraxofusp 6venetoclax 5fludarabine 5Whole-Body Irradiation 4Mycophenolic Acid 4Methotrexate 4Thiotepa 3Dexamethasone 3Cytarabine 3Cyclosporine 3Calcium Dobesilate 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Vincristine 2Tacrolimus 2Specimen Handling 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Cyclosporins 2Azacitidine 2relmapirazin 1prednylidene 1lorvotuzumab mertansine 1exifone 1deltacortene 1azathiopurine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blastic Plasmacytoid Dendritic Cell Neoplasm × prednylidene × Clear all
NCT04216524 2026-04-14

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡